NCT03622463 - A Trial of Antroquinonol in Patients With Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

July 9, 2019

Study Completion Date

July 9, 2019

Conditions

Atopic Dermatitis

Interventions

DRUG

Antroquinonol

Antroquinonol will be provided as a capsule-shaped which contain 50 mg Antroquinonol.

OTHER

Placebo

The matching placebo will be packaged as Antroquinonol with appearance identical in all aspects

Trial Locations (1)

Chung Shan Medical University Hospital, Taichung